1. Home
  2. ARDX

as 09-05-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Founded: 2007 Country:
United States
United States
Employees: N/A City: FREMONT
Market Cap: 882.9M IPO Year: 2014
Target Price: $10.50 AVG Volume (30 days): 3.5M
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.24 EPS Growth: N/A
52 Week Low/High: $3.21 - $7.18 Next Earning Date: 10-30-2025
Revenue: $386,146,000 Revenue Growth: 83.88%
Revenue Growth (this year): 16.83% Revenue Growth (next year): 28.55%

ARDX Daily Stock ML Predictions

Stock Insider Trading Activity of Ardelyx Inc. (ARDX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Williams Laura A ARDX Chief Patient Officer Aug 26 '25 Sell $6.12 80,000 $489,680.00 366,322
RAAB MICHAEL ARDX President & CEO Aug 21 '25 Sell $5.93 45,687 $271,001.58 1,502,250
Renz Justin A ARDX Chief Financial Officer Aug 21 '25 Sell $5.93 7,037 $41,741.37 409,052
Williams Laura A ARDX Chief Patient Officer Aug 21 '25 Sell $5.93 6,261 $37,138.37 366,322
Kelliher Mike ARDX Chief Business Officer Aug 21 '25 Sell $5.93 5,417 $32,132.02 276,741
GRAMMER ELIZABETH A ARDX See Remarks Aug 21 '25 Sell $5.93 5,841 $34,647.06 305,890
Foster Eric Duane ARDX Chief Commercial Officer Aug 21 '25 Sell $5.93 15,308 $90,802.46 301,498
MOTT DAVID M ARDX Director Jun 16 '25 Buy $3.63 200,000 $725,880.00 2,896,871
MOTT DAVID M ARDX Director Jun 9 '25 Buy $3.69 200,000 $737,260.00 2,896,871

Share on Social Networks: